Editing
Cabon Nanotube
Jump to navigation
Jump to search
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
<br>Quantitative lateral flow immunosensor using carbon nanotubes as label<br>Adeyabeba Abera and Jin-Woo Choi*<br>Received 28th June 2010, Accepted 26th August 2010<br>DOI: 10.1039/c0ay00412j<br>A novel immunosensor utilizing multi-walled carbon nanotube as label on a lateral flow system for<br>simple and quantitative electrical detection was investigated. Multi-walled carbon nanotubes<br>(MWCNTs) were first modified with polyvinylpyrrolidone (PVP) for uniform dispersion in aqueous<br>solution. Then, the MWCNTs were conjugated with human immunoglobulin G (IgG) using 1-(3-<br>(dimethylamino)-propyl)-3-ethylcarbodiimide hydrochloride (EDC) coupling chemistry. The lateral<br>flow immunosensor was made of nitrocellulose membrane that transports sample and reagents through<br>a porous structure by capillary action. The performance of the immunosensor was demonstrated using<br>human IgG as a model analyte competing with the conjugate (MWCNT-labeled human IgG) at the<br>capture zone. As a result of binding reaction between the conjugate and the immobilized Protein A at<br>the capture zone, the conjugated MWCNTs formed a conducting network at the capture zone<br>providing conductance measurement corresponding to the amount of captured conjugate. Quantitative<br>immunoassay response for the target human IgG was demonstrated in the range of 25 to 200 μg mlÀ1<br>without an additional amplification step. The presented immunosensing technique could be expanded<br>for the detection of various analyte-specific biomolecules with a potential for simple and rapid tests<br>suitable for point-of-care diagnostics.<br>1. Introduction<br>Lateral flow (LF) immunoassay is one of the most successful<br>point-of-care diagnostic tools commercially available for detecting<br>various health and environmental agents.1–6<br>A lateral flow<br>immunosensor is made of a porous membrane for both immobi-<br>lizing biological receptors and transporting sample reagents.<br>Sample reagents are transported in the lateral direction through<br>the porous membrane by capillary force and captured by the<br>biological receptors immobilized at the capture zone. LF immu-<br>nosensors are simple to use, low-cost, rapid, and portable with<br>relatively long shelf life. Examples of lateral flow diagnostics<br>include home pregnancy tests, detection of drugs of abuse, diag-<br>nosis of infectious diseases, and cancer markers. However, such<br>systems often suffer from low sensitivity, and are mostly restricted<br>to qualitative or semi-quantitative measurements.<br>Generally, LF immunosensors are based on optical detection<br>where tagged particles or enzymes provide visible signal generation<br>or amplification. Typically, colloidal gold is used as a label for<br>colorimetric detection traced by the visible color. Several efforts<br>have been made towards signal quantification using enhanced<br>colorimetric labels or conducting materials such as phosphorescent<br>nanoparticles,7 polyaniline,8 and polyaniline with colloidal gold.9<br>Colorimetric techniques are often limited by low sensitivity while<br>fluorescent techniques suffer from instability, photobleaching,<br>activation step, and requirement for a complicated reader device.<br>This work addresses such limitations by utilizing carbon<br>nanotubes (CNTs) as labeling material for direct electrical signal<br>measurement. CNTs have remarkable one-dimensional elec-<br>tronic conduction properties and large surface area, and allow<br>the adsorption of biomolecules for sensing.10–12 In order to utilize<br>these properties of carbon nanotubes for biosensing applications,<br>surface functionalization is necessary to uniformly disperse<br>CNTs in aqueous solution and immobilize biorecognition<br>molecules on the surface of the nanotubes. Adsorption of<br>surfactants and polymers on the surface of CNTs is considered as<br>an effective method to enhance the dispersion of CNTs without<br>affecting their properties.13–15 Compared to CNTs, other con-<br>ducting materials such as colloidal gold and polymer nanowires<br>do not possess the unique material properties suitable for surface<br>functionalization or maintain high electrical conduction after<br>binding reaction.9,16<br>In this work, a new immunoassay technique using carbon<br>nanotube labels on lateral flow system is introduced. The illus-<br>tration of this technique is shown in Fig. 1. MWCNTs are<br>dispersed in water with PVP using sonication. Adsorption of<br>PVP provides a thin and rough layer of organic coating by<br>wrapping around the MWCNTs. Human IgG is immobilized on<br>the bare (not covered by PVP) surface of the MWCNTs. The<br>MWCNT–human IgG conjugate is then applied on a lateral flow<br>immunosensor where the MWCNT–human IgG conjugate is to<br>be captured by immobilized Protein A at the capture zone. The<br>conjugated MWCNTs form a conducting network at the capture<br>zone corresponding to the amount of binding. Consequently,<br>quantitative signal can be obtained by simple resistance<br>measurement of the capture zone. Blocking schemes were also<br>implemented on the MWCNTs and the lateral flow strips to<br>address non-specific interaction.<br>2. Methods and experiments<br>2.1 Materials and reagents<br>Carboxylated multi-walled carbon nanotubes (purity > 95 wt%)<br>were obtained from Cheaptubes, Inc. (Brattleboro, VT). Hi-flow<br>Department of Electrical and Computer Engineering, Louisiana State<br>University, Baton Rouge, LA, 70803, USA; Web: www.ece.lsu.<br>edu/biomems/. E-mail: choi@ece.lsu.edu; Tel: +1-225-578-8764<br>This journal is © The Royal Society of Chemistry 2010<br>Anal. Methods, 2010, 2, 1819–1822 | 1819<br>TECHNICAL NOTE<br>www.rsc.org/methods | Analytical Methods<br>Downloaded on 30 December 2012<br>Published on 29 September 2010 on http://pubs.rsc.org | doi:10.1039/C0AY00412J<br>View Article Online / Journal Homepage / Table of Contents for this issue<br>Page 2<br>Plus nitrocellulose membranes (HF13502), glass fiber pads,<br>cellulose membranes, and a supporting card for lateral flow assay<br>were obtained from Millipore (Bedford, MA). Protein A sus-<br>pended in solution was obtained from BioVision, Inc. (Mountain<br>View, CA). Purified human immunoglobulin G (IgG, 6.2 mg mlÀ1)<br>suspended in 0.01 M sodium phosphate (0.15 M NaCl, pH 7.4)<br>was obtained from Sigma-Aldrich (St Louis, MO). Poly-<br>vinylpyrrolidone (PVP, Mw 10 000), bovine serum albumin (BSA),<br>Tween-20, glutaraldehyde, and 2-(N-morpholino)ethanesulfonic<br>acid (MES) were from Sigma-Aldrich. 1-(3-(Dimethylamino)-<br>propyl)-3-ethylcarbodiimide hydrochloride (EDC) and N-<br>hydroxysulfosuccinimide (sulfo-NHS) were obtained from<br>Thermo Fisher Scientific, Inc. (Rockford, IL). All immunore-<br>agents were diluted in pH 7.4 phosphate saline buffer (PBS) unless<br>noted otherwise.<br>2.2 MWCNT–antibody conjugation<br>In order to start the conjugation process, 1.5 mg of carboxylated<br>MWCNTs were dispersed in 2 ml of deionized (DI) water with 0.6<br>mg of PVP. The solution was sonicated for 4 hours in an ultra-<br>sonic bath at 27 C to exfoliate the MWCNTs and accelerate the<br>dispersion. The dispersed solution was mixed with 1 ml of EDC<br>(0.4 M) and sulfo-NHS (0.1 M) in pH 6.1 MES buffer. The<br>solution was left to react for 30 minutes with gentle agitation at<br>room temperature. The mixture was microcentrifuged at 13 000<br>rpm for 3 minutes with PBS buffer and the supernatant was dis-<br>carded. The washing and re-suspending process was repeated<br>three times to remove excess reagents. Human IgG solution was<br>prepared at 200 μg mlÀ1 by diluting with PBS buffer for conju-<br>gation. The solution containing functionalized MWCNTs was<br>then mixed with 100 μl of the human IgG solution and left to react<br>overnight at 4 C. This mixture was centrifuged at 13 000 rpm for<br>3 minutes and the supernatant was discarded. The washing and re-<br>suspending process was repeated three times to remove unbound<br>human IgG, and the resulting MWCNT–antibody conjugate<br>solution was kept at 4 C until use.<br>2.3 Preparation of lateral flow immunosensors<br>A nitrocellulose membrane was used as a detection pad with<br>designated capture zone for immobilizing Protein A. Fiber glass<br>and cellulose membranes were used for sample application and<br>for absorption of excess reagents by placing them at the two ends<br>of the nitrocellulose membrane, respectively. The LF immuno-<br>strips were prepared following general procedure reported else-<br>where.7,9 First, a nitrocellulose membrane was saturated with<br>10% (v/v) methanol in deionized (DI) water for 30 minutes to<br>remove any residue and dried in air at room temperature. The<br>membrane was then treated with 0.5% (v/v) glutaraldehyde<br>solution to strengthen the immobilization of Protein A on the<br>nitrocellulose membrane and rinsed with DI water. After drying,<br>Protein A diluted in PBS buffer to 1 mg mlÀ1 was immobilized at<br>a designated capture zone by dragging a dispenser with manual<br>control. The membrane was then incubated with 2% BSA and<br>0.05% (v/v) Tween-20 in PBS for 1 hour in order to block the<br>membrane from making unwanted binding. The membrane was<br>rinsed with PBS containing 0.05% (v/v) Tween-20 to remove the<br>excess blocking reagent and left to dry at room temperature.<br>3. Results and discussion<br>A lateral flow immunosensor was developed by assembling<br>a lateral flow strip with sample application, detection, and<br>absorbent pads. The specific binding reaction was based on<br>immobilized Protein A and human IgG that was detected by the<br>conjugated MWCNT labels. Since CNTs have inherent affinity<br>to biological elements causing non-specific binding, control tests<br>were conducted at different functionalization steps. First, the<br>PVP treated MWCNTs were applied to the LF immunosensors<br>to bind with immobilized Protein A. As a result, unwanted<br>binding of the MWCNTs with Protein A at the capture zone was<br>observed as shown in Fig. 2(a). This non-specific binding could<br>have been caused by the affinity of the exposed MWCNTs<br>surface to the Protein A. Next, the crosslinking agents, EDC and<br>sulfo-NHS, were added to the PVP treated carbon nanotubes<br>and the same test was repeated. In this case, no binding reaction<br>was observed between the MWCNTs and Protein A at the<br>capture zone as shown in Fig. 2(b). This result showed that the<br>surfaces of the MWCNTs were completely covered by the PVP<br>and the amide coupling agents limiting unoccupied sites from<br>non-specific binding. Finally, MWCNT–IgG conjugate solution<br>was applied, where binding between human IgG and Protein A<br>was evident at the capture zone as shown in Fig. 2(c). Scanning<br> electron microscopy (SEM) was used to examine the capture<br>zone, where the MWCNTs formed a conducting network as<br>a result of binding. Fig. 3 shows SEM image of the nitrocellulose<br>membrane without MWCNT labels and with varying concen-<br>tration of MWCNT labels corresponding to the amount of<br>binding.<br>Prior to the immunoassay test, varying concentration of the<br>conjugate solutions ranging from 0 to 200 μg mlÀ1 was prepared<br>by dilution in PBS buffer in order to determine the detection limit<br>of the conjugate solution. 50 μl of each solution were applied to<br>the LF immunosensors where the conjugated human IgG was<br>captured by the Protein A at the capture zone resulting in<br>colorimetric signal as shown in Fig. 4. As depicted in Fig. 4, the<br>color intensity of the signal was stronger for higher concentration<br>of the conjugated human IgG. For quantitative analysis of the<br>binding reaction, the resistance across the capture line was<br>measured after the complete development of the visible signal<br>($15 minutes). The measured electrical resistance decreased as<br>the concentration of the MWCNT–human IgG conjugate<br>increased due to the increased amount of MWCNTs forming<br>a conducting network. Three replications of the immunosensors<br>with same conjugate concentration were tested for consistency of<br>the measurements. The electrical resistance was measured using<br>electrodes with 3 mm spacing and while maintaining same<br>contact resistance.<br>The developed immunosensor was used with increasing<br>concentration of human IgG as target analyte in solution.<br>Concentration of the human IgG target analyte ranged from 25<br>to 200 μg mlÀ1 and the concentration of the conjugate solution<br>was fixed at 200 μg mlÀ1. Each target analyte solution was briefly<br>mixed with the conjugate and then the mixture was applied to the<br>LF immunosensor as a one-step immunoassay process. As the<br>sample solution moved across the capture zone, a competitive<br>immunoassay reaction between the conjugated human IgG and<br>those in the solution occurred. This produced a detection signal<br>by the MWCNTs across the capture line varying in color<br>intensity that was inversely proportional to the amount of<br>human IgG target analyte captured as shown in Fig. 5(a). The<br>detection signals were visible with the application of only 20 μl,<br>and saturation occurred with the application of 50 μl of total<br>sample solutions within 15 minutes. The visibility of the capture<br>zone decreased with increasing target human IgG concentration.<br>As the concentration of the target analyte increased, it occupied<br>more binding sites limiting the binding reaction between the<br>conjugated human IgG and the Protein A. The corresponding<br>measured results in Fig. 5(b) clearly show that the electrical<br>resistance increased with increasing concentration of the target<br>human IgG. Although the visibility of capture lines decreased with<br>increasing target IgG concentration (100, 150, and 200 μg mlÀ1)<br> <br>Quantitative lateral flow immunosensor using carbon nanotubes as label<br>Adeyabeba Abera and Jin-Woo Choi*<br>Received 28th June 2010, Accepted 26th August 2010<br>DOI: 10.1039/c0ay00412j<br>A novel immunosensor utilizing multi-walled carbon nanotube as label on a lateral flow system for<br>simple and quantitative electrical detection was investigated. Multi-walled carbon nanotubes<br>(MWCNTs) were first modified with polyvinylpyrrolidone (PVP) for uniform dispersion in aqueous<br>solution. Then, the MWCNTs were conjugated with human immunoglobulin G (IgG) using 1-(3-<br>(dimethylamino)-propyl)-3-ethylcarbodiimide hydrochloride (EDC) coupling chemistry. The lateral<br>flow immunosensor was made of nitrocellulose membrane that transports sample and reagents through<br>a porous structure by capillary action. The performance of the immunosensor was demonstrated using<br>human IgG as a model analyte competing with the conjugate (MWCNT-labeled human IgG) at the<br>capture zone. As a result of binding reaction between the conjugate and the immobilized Protein A at<br>the capture zone, the conjugated MWCNTs formed a conducting network at the capture zone<br>providing conductance measurement corresponding to the amount of captured conjugate. Quantitative<br>immunoassay response for the target human IgG was demonstrated in the range of 25 to 200 μg mlÀ1<br>without an additional amplification step. The presented immunosensing technique could be expanded<br>for the detection of various analyte-specific biomolecules with a potential for simple and rapid tests<br>suitable for point-of-care diagnostics.<br>1. Introduction<br>Lateral flow (LF) immunoassay is one of the most successful<br>point-of-care diagnostic tools commercially available for detecting<br>various health and environmental agents.1–6<br>A lateral flow<br>immunosensor is made of a porous membrane for both immobi-<br>lizing biological receptors and transporting sample reagents.<br>Sample reagents are transported in the lateral direction through<br>the porous membrane by capillary force and captured by the<br>biological receptors immobilized at the capture zone. LF immu-<br>nosensors are simple to use, low-cost, rapid, and portable with<br>relatively long shelf life. Examples of lateral flow diagnostics<br>include home pregnancy tests, detection of drugs of abuse, diag-<br>nosis of infectious diseases, and cancer markers. However, such<br>systems often suffer from low sensitivity, and are mostly restricted<br>to qualitative or semi-quantitative measurements.<br>Generally, LF immunosensors are based on optical detection<br>where tagged particles or enzymes provide visible signal generation<br>or amplification. Typically, colloidal gold is used as a label for<br>colorimetric detection traced by the visible color. Several efforts<br>have been made towards signal quantification using enhanced<br>colorimetric labels or conducting materials such as phosphorescent<br>nanoparticles,7 polyaniline,8 and polyaniline with colloidal gold.9<br>Colorimetric techniques are often limited by low sensitivity while<br>fluorescent techniques suffer from instability, photobleaching,<br>activation step, and requirement for a complicated reader device.<br>This work addresses such limitations by utilizing carbon<br>nanotubes (CNTs) as labeling material for direct electrical signal<br>measurement. CNTs have remarkable one-dimensional elec-<br>tronic conduction properties and large surface area, and allow<br>the adsorption of biomolecules for sensing.10–12 In order to utilize<br>these properties of carbon nanotubes for biosensing applications,<br>surface functionalization is necessary to uniformly disperse<br>CNTs in aqueous solution and immobilize biorecognition<br>molecules on the surface of the nanotubes. Adsorption of<br>surfactants and polymers on the surface of CNTs is considered as<br>an effective method to enhance the dispersion of CNTs without<br>affecting their properties.13–15 Compared to CNTs, other con-<br>ducting materials such as colloidal gold and polymer nanowires<br>do not possess the unique material properties suitable for surface<br>functionalization or maintain high electrical conduction after<br>binding reaction.9,16<br>In this work, a new immunoassay technique using carbon<br>nanotube labels on lateral flow system is introduced. The illus-<br>tration of this technique is shown in Fig. 1. MWCNTs are<br>dispersed in water with PVP using sonication. Adsorption of<br>PVP provides a thin and rough layer of organic coating by<br>wrapping around the MWCNTs. Human IgG is immobilized on<br>the bare (not covered by PVP) surface of the MWCNTs. The<br>MWCNT–human IgG conjugate is then applied on a lateral flow<br>immunosensor where the MWCNT–human IgG conjugate is to<br>be captured by immobilized Protein A at the capture zone. The<br>conjugated MWCNTs form a conducting network at the capture<br>zone corresponding to the amount of binding. Consequently,<br>quantitative signal can be obtained by simple resistance<br>measurement of the capture zone. Blocking schemes were also<br>implemented on the MWCNTs and the lateral flow strips to<br>address non-specific interaction.<br>2. Methods and experiments<br>2.1 Materials and reagents<br>Carboxylated multi-walled carbon nanotubes (purity > 95 wt%)<br>were obtained from Cheaptubes, Inc. (Brattleboro, VT). Hi-flow<br>Department of Electrical and Computer Engineering, Louisiana State<br>University, Baton Rouge, LA, 70803, USA; Web: www.ece.lsu.<br>edu/biomems/. E-mail: choi@ece.lsu.edu; Tel: +1-225-578-8764<br>This journal is © The Royal Society of Chemistry 2010<br>Anal. Methods, 2010, 2, 1819–1822 | 1819<br>TECHNICAL NOTE<br>www.rsc.org/methods | Analytical Methods<br>Downloaded on 30 December 2012<br>Published on 29 September 2010 on http://pubs.rsc.org | doi:10.1039/C0AY00412J<br>View Article Online / Journal Homepage / Table of Contents for this issue<br>Page 2<br>Plus nitrocellulose membranes (HF13502), glass fiber pads,<br>cellulose membranes, and a supporting card for lateral flow assay<br>were obtained from Millipore (Bedford, MA). Protein A sus-<br>pended in solution was obtained from BioVision, Inc. (Mountain<br>View, CA). Purified human immunoglobulin G (IgG, 6.2 mg mlÀ1)<br>suspended in 0.01 M sodium phosphate (0.15 M NaCl, pH 7.4)<br>was obtained from Sigma-Aldrich (St Louis, MO). Poly-<br>vinylpyrrolidone (PVP, Mw 10 000), bovine serum albumin (BSA),<br>Tween-20, glutaraldehyde, and 2-(N-morpholino)ethanesulfonic<br>acid (MES) were from Sigma-Aldrich. 1-(3-(Dimethylamino)-<br>propyl)-3-ethylcarbodiimide hydrochloride (EDC) and N-<br>hydroxysulfosuccinimide (sulfo-NHS) were obtained from<br>Thermo Fisher Scientific, Inc. (Rockford, IL). All immunore-<br>agents were diluted in pH 7.4 phosphate saline buffer (PBS) unless<br>noted otherwise.<br>2.2 MWCNT–antibody conjugation<br>In order to start the conjugation process, 1.5 mg of carboxylated<br>MWCNTs were dispersed in 2 ml of deionized (DI) water with 0.6<br>mg of PVP. The solution was sonicated for 4 hours in an ultra-<br>sonic bath at 27 C to exfoliate the MWCNTs and accelerate the<br>dispersion. The dispersed solution was mixed with 1 ml of EDC<br>(0.4 M) and sulfo-NHS (0.1 M) in pH 6.1 MES buffer. The<br>solution was left to react for 30 minutes with gentle agitation at<br>room temperature. The mixture was microcentrifuged at 13 000<br>rpm for 3 minutes with PBS buffer and the supernatant was dis-<br>carded. The washing and re-suspending process was repeated<br>three times to remove excess reagents. Human IgG solution was<br>prepared at 200 μg mlÀ1 by diluting with PBS buffer for conju-<br>gation. The solution containing functionalized MWCNTs was<br>then mixed with 100 μl of the human IgG solution and left to react<br>overnight at 4 C. This mixture was centrifuged at 13 000 rpm for<br>3 minutes and the supernatant was discarded. The washing and re-<br>suspending process was repeated three times to remove unbound<br>human IgG, and the resulting MWCNT–antibody conjugate<br>solution was kept at 4 C until use.<br>2.3 Preparation of lateral flow immunosensors<br>A nitrocellulose membrane was used as a detection pad with<br>designated capture zone for immobilizing Protein A. Fiber glass<br>and cellulose membranes were used for sample application and<br>for absorption of excess reagents by placing them at the two ends<br>of the nitrocellulose membrane, respectively. The LF immuno-<br>strips were prepared following general procedure reported else-<br>where.7,9 First, a nitrocellulose membrane was saturated with<br>10% (v/v) methanol in deionized (DI) water for 30 minutes to<br>remove any residue and dried in air at room temperature. The<br>membrane was then treated with 0.5% (v/v) glutaraldehyde<br>solution to strengthen the immobilization of Protein A on the<br>nitrocellulose membrane and rinsed with DI water. After drying,<br>Protein A diluted in PBS buffer to 1 mg mlÀ1 was immobilized at<br>a designated capture zone by dragging a dispenser with manual<br>control. The membrane was then incubated with 2% BSA and<br>0.05% (v/v) Tween-20 in PBS for 1 hour in order to block the<br>membrane from making unwanted binding. The membrane was<br>rinsed with PBS containing 0.05% (v/v) Tween-20 to remove the<br>excess blocking reagent and left to dry at room temperature.<br>3. Results and discussion<br>A lateral flow immunosensor was developed by assembling<br>a lateral flow strip with sample application, detection, and<br>absorbent pads. The specific binding reaction was based on<br>immobilized Protein A and human IgG that was detected by the<br>conjugated MWCNT labels. Since CNTs have inherent affinity<br>to biological elements causing non-specific binding, control tests<br>were conducted at different functionalization steps. First, the<br>PVP treated MWCNTs were applied to the LF immunosensors<br>to bind with immobilized Protein A. As a result, unwanted<br>binding of the MWCNTs with Protein A at the capture zone was<br>observed as shown in Fig. 2(a). This non-specific binding could<br>have been caused by the affinity of the exposed MWCNTs<br>surface to the Protein A. Next, the crosslinking agents, EDC and<br>sulfo-NHS, were added to the PVP treated carbon nanotubes<br>and the same test was repeated. In this case, no binding reaction<br>was observed between the MWCNTs and Protein A at the<br>capture zone as shown in Fig. 2(b). This result showed that the<br>surfaces of the MWCNTs were completely covered by the PVP<br>and the amide coupling agents limiting unoccupied sites from<br>non-specific binding. Finally, MWCNT–IgG conjugate solution<br>was applied, where binding between human IgG and Protein A<br>was evident at the capture zone as shown in Fig. 2(c). Scanning<br>Fig. 1 Illustration of the detection principle using carbon nanotubes as label for quantitative lateral flow immunosensing in competitive format. Carbon<br>nanotubes form a conducting network at the capture zone corresponding to the amount of binding reaction. Consequently, quantitative signal can be<br>obtained by simple resistance measurement of the capture zone.<br>1820 | Anal. Methods, 2010, 2, 1819–1822<br>This journal is © The Royal Society of Chemistry 2010<br>Downloaded on 30 December 2012<br>Published on 29 September 2010 on http://pubs.rsc.org | doi:10.1039/C0AY00412J<br>View Article Online<br>Page 3<br>electron microscopy (SEM) was used to examine the capture<br>zone, where the MWCNTs formed a conducting network as<br>a result of binding. Fig. 3 shows SEM image of the nitrocellulose<br>membrane without MWCNT labels and with varying concen-<br>tration of MWCNT labels corresponding to the amount of<br>binding.<br>Prior to the immunoassay test, varying concentration of the<br>conjugate solutions ranging from 0 to 200 μg mlÀ1 was prepared<br>by dilution in PBS buffer in order to determine the detection limit<br>of the conjugate solution. 50 μl of each solution were applied to<br>the LF immunosensors where the conjugated human IgG was<br>captured by the Protein A at the capture zone resulting in<br>colorimetric signal as shown in Fig. 4. As depicted in Fig. 4, the<br>color intensity of the signal was stronger for higher concentration<br>of the conjugated human IgG. For quantitative analysis of the<br>binding reaction, the resistance across the capture line was<br>measured after the complete development of the visible signal<br>($15 minutes). The measured electrical resistance decreased as<br>the concentration of the MWCNT–human IgG conjugate<br>increased due to the increased amount of MWCNTs forming<br>a conducting network. Three replications of the immunosensors<br>with same conjugate concentration were tested for consistency of<br>the measurements. The electrical resistance was measured using<br>electrodes with 3 mm spacing and while maintaining same<br>contact resistance.<br>The developed immunosensor was used with increasing<br>concentration of human IgG as target analyte in solution.<br>Concentration of the human IgG target analyte ranged from 25<br>to 200 μg mlÀ1 and the concentration of the conjugate solution<br>was fixed at 200 μg mlÀ1. Each target analyte solution was briefly<br>mixed with the conjugate and then the mixture was applied to the<br>LF immunosensor as a one-step immunoassay process. As the<br>sample solution moved across the capture zone, a competitive<br>immunoassay reaction between the conjugated human IgG and<br>those in the solution occurred. This produced a detection signal<br>by the MWCNTs across the capture line varying in color<br>intensity that was inversely proportional to the amount of<br>human IgG target analyte captured as shown in Fig. 5(a). The<br>detection signals were visible with the application of only 20 μl,<br>and saturation occurred with the application of 50 μl of total<br>sample solutions within 15 minutes. The visibility of the capture<br>zone decreased with increasing target human IgG concentration.<br>As the concentration of the target analyte increased, it occupied<br>more binding sites limiting the binding reaction between the<br>conjugated human IgG and the Protein A. The corresponding<br>measured results in Fig. 5(b) clearly show that the electrical<br>resistance increased with increasing concentration of the target<br>human IgG. Although the visibility of capture lines decreased with<br>increasing target IgG concentration (100, 150, and 200 μg mlÀ1),<br>Fig. 2 Non-specific adsorption on the nitrocellulose membrane: (a)<br>MWCNTs partially coated with PVP were captured by Protein A due to<br>non-specific adsorption which must be addressed to avoid false signal; (b)<br>almost no detection signal was observed at the capture zone indicating<br>that the surface of the MWCNTs were completely covered eliminating<br>non-specific adsorption, and (c) selective binding between the MWCNT–<br>human IgG conjugate and immobilized Protein A.<br>Fig. 3 SEM images of the MWCNT network at the capture zone: (a) before sample application; (b) lower MWCNT coverage due to a smaller number<br>of binding; and (c) higher MWCNT coverage due to a larger number of binding. The scale bar is 1 μm.<br>Fig. 4 Calibration results using conjugate solutions in different<br>concentrations. MWCNTs as label provided a quantitative detection<br>capability.<br>This journal is © The Royal Society of Chemistry 2010<br>Anal. Methods, 2010, 2, 1819–1822 | 1821<br>Downloaded on 30 December 2012<br>Published on 29 September 2010 on http://pubs.rsc.org | doi:10.1039/C0AY00412J<br>View Article Online<br>Page 4<br>the electrical measurements clearly showed differences corre-<br>sponding to the various concentrations at all levels.<br>4. Conclusions<br>A lateral flow immunosensing technique using carbon nanotubes<br>as a label was effectively demonstrated for quantitative antibody<br>detection based on simple electrical measurements. The surface<br>of the MWCNTs was partially modified with PVP for uniform<br>dispersion in aqueous solutions. Further functionalization steps<br>were conducted to attach antibodies on the exposed surface of<br>MWCNTs utilizing EDC/sulfo-NHS chemistry. The modified<br>MWCNTs successfully provided both direct colorimetric and<br>conductimetric measurements for antibody binding without addi-<br>tion amplification step. SEM images showed the MWCNT<br>network formed as a result of antibody binding at the capture zone.<br>The lateral flow system facilitated the binding reaction and reagent<br>handling in a simple and convenient manner. This immunosensing<br>technique is easy for integration and requires ordinary tools for<br>signal measurement. Therefore, it holds the potential for quanti-<br>tative determination of various antibodies and antigen in a point-<br>of-care setup. The detection limit and time could be improved<br>further with proper optimization of the conjugating process and<br>the lateral flow system<br> <br> [[Category:Lateral_Flow]]
Summary:
Please note that all contributions to ELN may be edited, altered, or removed by other contributors. If you do not want your writing to be edited mercilessly, then do not submit it here.
You are also promising us that you wrote this yourself, or copied it from a public domain or similar free resource (see
ELN:Copyrights
for details).
Do not submit copyrighted work without permission!
Cancel
Editing help
(opens in new window)
Navigation menu
Personal tools
Not logged in
Talk
Contributions
Create account
Log in
Namespaces
Page
Discussion
English
Views
Read
Edit
View history
More
Search
Navigation
Category:
Main page
To Do
Tasks
My ELN
Weekly Reports
Buffer Recipe
SOP
Protocols
Inventories
Projects
Products
Customers
Contacts
Suppliers
Vectors
Vector Map
Clones
Cloning
Sequencing
NGS
Protein Expression
Purchaseing
QC
293 Expression
CHO Expression
Sf9 Expression
Protein Purification
Stem Cells
Cytokines
Protein Kinases
GPCR
Cell Lines
Competent Cells
Viral Proteins
VLP
Baculovirus
AAV
Adenovirus
Lentivirus
Virus Titering
Antibodies
Transfection
ELISA
qPCR RT-PCR
ImmunoAssay
Multiplex BioAssa
Lateral_Flow
Conjugation
Compounds Synthesis
BioEngineering
GenomeEngineering
Services
Software
Ideas
Links
Knowledgebase
Employees
Company
Tools
What links here
Related changes
Page information
Navigation
Special pages